)
Assertio (ASRT) investor relations material
Assertio Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
The annual meeting will be held virtually on May 5, 2026, with stockholders able to participate, submit questions, and vote online after pre-registration.
Key 2025 business results include appointing a new CEO, integrating operations, amending a major supply agreement, divesting legacy litigation exposure, and settling significant legal matters.
Full year 2025 product sales reached $117.1 million, with a GAAP net loss of $30.4 million and non-GAAP adjusted EBITDA of $22.7 million.
A 1-for-15 reverse stock split was effected on December 26, 2025.
Voting matters and shareholder proposals
Stockholders will vote on: (1) election of six directors, (2) amendment to increase shares under the 2014 Omnibus Incentive Plan, (3) advisory approval of executive compensation, and (4) ratification of Grant Thornton LLP as auditor.
The Board recommends voting FOR all proposals.
Shareholders may submit proposals for the 2027 meeting by December 7, 2026, and director nominations must comply with advance notice provisions.
Board of directors and corporate governance
The Board consists of six directors, with a majority being independent under Nasdaq rules.
Board leadership is separated between an independent Chairman and the CEO.
Three standing committees: Audit, Compensation, and Nominating & Corporate Governance, all meeting independence requirements.
Director nomination protocol emphasizes ethics, diversity, and relevant business experience.
Stockholder communications and a Code of Ethics are in place.
- FY2025 sales and adjusted EBITDA surpassed guidance, with ROLVEDON driving 2026 growth outlook.ASRT
Q4 202516 Mar 2026 - ROLVEDON growth offset Indocin decline; sales $30.7M, net loss $3.7M, cash $88.4M.ASRT
Q2 20242 Feb 2026 - Rolvedon drives growth with $60M–$100M potential, supported by strong cash flow and new leadership.ASRT
Small-Cap Growth Virtual Investor Conference1 Feb 2026 - Rolvedon drives growth as expansion and clinical initiatives position for long-term value.ASRT
Maxim Group’s 2024 Healthcare Virtual Summit19 Jan 2026 - Q3 sales were $28.7M as Indocin fell, Rolvedon held steady, and margins improved.ASRT
Q3 202415 Jan 2026 - Rolvedon growth offsets Indocin decline; 2025 targets $108–$123M sales, $10–$19M EBITDA.ASRT
Q4 202426 Dec 2025 - Proxy seeks approval for director elections, equity plan expansion, reverse split, and auditor ratification.ASRT
Proxy Filing2 Dec 2025 - Proxy seeks approval for director elections, equity plan expansion, reverse split, and auditor ratification.ASRT
Proxy Filing2 Dec 2025 - Transformation phase prioritizes Rolvedon, Sympazan, and M&A for future growth.ASRT
Alliance Global Partners Healthcare Company Showcase26 Nov 2025
Next Assertio earnings date
Next Assertio earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage